Brief: Syneos Health And KX Partner To Pioneer Data-Driven Transformation In Biopharmaceutical Asset Development
22/03/2023 11:31
March 22 (Reuters) - Syneos Health Inc SYNH.O :
* SYNEOS HEALTH AND KX PARTNER TO PIONEER DATA-DRIVEN
TRANSFORMATION IN BIOPHARMACEUTICAL ASSET DEVELOPMENT
Source text for Eikon: ID:nGNX4wqjyt
Further company coverage: SYNH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Syneos Health
See all newsHayward Holdings rises on S&P Smallcap 600 inclusion
Brief: Syneos Health And Oracle To Expand Partnership
Large LBO bond sales could prompt September US junk debt rush
Brief: SYNEOS HEALTH AND STAR PARENT ANNOUNCE PROPOSED $1.70 BILLION OFFERING OF SENIOR SECURED NOTES
Brief: Syneos Health Announces Agreement With Aotearoa Clinical Trials, Expanding Clinical Trial Capabilities Across Range Of Therapeutic Areas In New Zealand